Combination verteporfin photodynamic therapy ranibizumab-dexamethasone in choroidal neovascularization due to age-related macular degeneration: results of a phase II randomized trial.

Gallemore, Ron P; Wallsh, Josh; Hudson, Henry L; Ho, Allen C; Chace, Richard; Pearlman, Joel

Gallemore, Ron P; Wallsh, Josh; Hudson, Henry L; Ho, Allen C; Chace, Richard; Pearlman, Joel.

Afiliación

Gallemore RP; Retina Macula Institute, Torrance, CA.
Wallsh J; Retina Macula Institute, Torrance, CA.
Hudson HL; Retina Centers PC, Tucson, AZ.
Ho AC; Wills Eye Institute, Philadelphia, PA.
Chace R; Eyesight Ophthalmic Services, Portsmouth, NH.
Pearlman J; Retinal Consultants Medical Group, Sacramento, CA, USA.

Clin Ophthalmol ; 11: 223-231, 2017.

Article en En | MEDLINE | ID: mdl-28182161

Palabras clave

age-related macular degeneration (AMD); combination therapy; photodynamic therapy (PDT); ranibizumab; verteporfin

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Clin Ophthalmol Año: 2017 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google